York Capital Management Global Advisors’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

York Capital Management Global Advisors’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,894,527	Closed	-$327M	–	149
2015 Q1	$327M	Buy	1,894,527 +1,208,098	+176%	+$177M	2.25%	11
2014 Q4	$78.9M	Sell	686,429 -219,757	-24%	-$26.6M	0.71%	43
2014 Q3	$142M	Buy	+906,186	New	+$131M	1.43%	25

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

York Capital Management Global Advisors's SLXP Position: Q2 2015 in Review

York Capital Management Global Advisors sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,894,527 shares — an estimated $327M sold.

York Capital Management Global Advisors first reported a position in SLXP in Q3 2014 and held it in 3 quarters. The position peaked at $327M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

York Capital Management Global Advisors reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
York Capital Management Global Advisors sold 1,894,527 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $327M.
York Capital Management Global Advisors first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 3 quarters.
York Capital Management Global Advisors's SALIX PHARMACEUTICALS LTD DEL position peaked at $327M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on York Capital Management Global Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.